This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.
Press Releases
Non-regulatory
Regulatory
New order valued at 15.2 MSEK smashes previous company record
Regulatory
Correction: Consolidated cash flow analysis interim report January-September 2022 Redsense Medical AB (publ)
Regulatory
Interim Report Q3 – July – September, 2022 Redsense Medical AB (publ)
Non-regulatory
Valberedning utsedd inför årsstämman 2023 i Redsense Medical AB
Regulatory